The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Acute Pancreatitis Management

Comprehensive management of acute pancreatic inflammation including risk stratification, fluid resuscitation, nutrition support, and complication monitoring based on Atlanta classification and current evidence.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dahiliye (İç Hastalıkları) department. Book Appointment →

What is Acute Pancreatitis Management?

Acute pancreatitis is a sudden inflammatory process of the pancreas resulting from premature activation of digestive enzymes within acinar cells, with autodigestion, edema, hemorrhage, and possible necrosis. Diagnosis requires two of three criteria: typical epigastric pain radiating to the back, lipase or amylase >3x upper limit, and characteristic imaging.

The most common etiologies are gallstones (40-50%) and alcohol (20-30%); other causes include hypertriglyceridemia (>1000 mg/dL), post-ERCP, drug-induced (azathioprine, valproate, GLP-1 analogs in rare cases), hypercalcemia, autoimmune (IgG4), genetic (PRSS1, SPINK1, CFTR), and idiopathic. Severity is stratified using the revised Atlanta classification into mild (no organ failure or local complications), moderately severe (transient organ failure <48 hours or local complications), and severe (persistent organ failure >48 hours).

Management hinges on goal-directed fluid resuscitation, pain control, early enteral nutrition, and treatment of the underlying cause. Imaging with contrast-enhanced CT after 72-96 hours identifies necrosis; MRCP detects choledocholithiasis. Complications include peripancreatic fluid collections, walled-off necrosis, infected necrosis (requiring step-up minimally invasive necrosectomy), pseudocyst, splanchnic vein thrombosis, and pancreatic insufficiency.

Symptoms

Severe persistent epigastric pain radiating to the back, worse supine, partial relief leaning forward
Nausea and vomiting unrelieved by fasting
Abdominal distension, ileus, decreased bowel sounds
Tachycardia, tachypnea, hypotension in severe cases
Low-grade fever, occasionally jaundice with biliary etiology
Cullen's sign (periumbilical bruising) or Grey-Turner sign (flank bruising) in hemorrhagic necrosis
Altered mental status, hypoxemia, oliguria signaling organ failure

Risk Factors

Gallstone disease, especially with small stones or microlithiasis
Heavy alcohol consumption (chronic and binge)
Hypertriglyceridemia (>1000 mg/dL), uncontrolled diabetes
Recent ERCP, especially with sphincter manipulation
Drugs (azathioprine, 6-mercaptopurine, valproate, didanosine, estrogens)
Hypercalcemia (hyperparathyroidism, malignancy)
Genetic predisposition (PRSS1, SPINK1, CFTR mutations) and autoimmune (IgG4) pancreatitis

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Sudden severe upper abdominal pain radiating to the back
  • Persistent vomiting with inability to tolerate oral intake
  • Fever, jaundice, or signs of biliary obstruction
  • Symptoms of organ dysfunction (shortness of breath, confusion, decreased urine)
  • Recurrent pancreatitis episodes for etiologic workup
  • Suspected complications (palpable mass, ongoing fever after 7-10 days)
  • Family history of pancreatitis or unexplained recurrent pancreatitis for genetic evaluation

Treatment Methods

01
Goal-directed early aggressive fluid resuscitation with lactated Ringer's (5-10 mL/kg/hr initially, titrated to urine output >0.5 mL/kg/hr and hemodynamic targets)
02
Multimodal analgesia (IV opioids, regional blocks if available); avoid prolonged NSAIDs in acute kidney injury
03
Early enteral nutrition (oral or NJ tube) within 24-72 hours; reserve TPN for cases unable to tolerate enteral feeding
04
Etiology-directed therapy: urgent ERCP within 24-48 hours for cholangitis or biliary obstruction; cholecystectomy during same admission for mild biliary pancreatitis; insulin/plasmapheresis for severe hypertriglyceridemia
05
Avoid prophylactic antibiotics; reserve for documented infected necrosis (carbapenem with anaerobic coverage) or extrapancreatic infection
06
Step-up approach for infected necrosis: percutaneous drainage first, followed by minimally invasive video-assisted retroperitoneal debridement or endoscopic necrosectomy if needed
07
Severity monitoring with BISAP, APACHE-II, and serial labs; ICU admission for persistent organ failure and multidisciplinary care including pancreatic enzyme replacement and post-discharge etiology workup

Which Department to Visit?

You can visit our Dahiliye (İç Hastalıkları) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dahiliye (İç Hastalıkları) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.